Form 4: Eastman Chemical Co. Executive Acquires Stock Options and Restricted Stock Units
SEC Filing Form 4
Bosede Ikeolu Gbadegesin, SVP, CLO & Corporate Secretary of Eastman Chemical Co., reports acquisition of stock options and restricted stock units.
Summary
- Bosede Ikeolu Gbadegesin, a Senior Vice President, CLO, and Corporate Secretary at Eastman Chemical Co. [EMN], filed a Form 4.
- The filing reports the acquisition of employee stock options and restricted stock units.
- On February 20, 2025, Gbadegesin acquired 14,460 employee stock options with an exercise price of $100.56.
- These options become exercisable in three equal installments starting February 20, 2026.
- Gbadegesin also acquired 2,762 restricted stock units, which will vest and payout in unrestricted shares on February 20, 2028, subject to continued employment.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing and does not inherently convey positive or negative sentiment. It simply reports transactions.
Positives
- The acquisition of stock options and restricted stock units aligns the executive's interests with those of the shareholders.
- The vesting schedule of the stock options and restricted stock units incentivizes long-term performance and retention.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting schedule implies continued employment is expected.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding insider transactions in publicly traded companies. This filing indicates compensation practices at Eastman Chemical Co.
Comparison to Industry Standards
- Stock option and restricted stock unit grants are common compensation practices for executives in publicly traded companies like Eastman Chemical Co.
- Companies such as Dow Chemical, BASF, and LyondellBasell also utilize similar equity-based compensation plans to align executive interests with shareholder value.
- The vesting schedules and exercise prices are generally determined based on company performance, industry benchmarks, and individual executive contributions.
Stakeholder Impact
- The stock options and restricted stock units align the executive's interests with those of the shareholders, potentially leading to decisions that benefit shareholder value.
- The vesting schedule incentivizes the executive to remain with the company, providing stability and experience.
Key Dates
| Date | Description |
|---|---|
| 02/20/2025 | Date of transaction: Acquisition of stock options and restricted stock units |
| 02/20/2026 | First vesting date for one-third of the stock options |
| 02/20/2027 | Second vesting date for one-third of the stock options |
| 02/20/2028 | Final vesting date for one-third of the stock options and vesting date for restricted stock units |
| 02/19/2035 | Expiration date for the stock options |
| 02/24/2025 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.